These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 6230281)

  • 1. T-cell subsets in liver diseases.
    Eggink HF; Houthoff HJ; Poppema S
    Gastroenterology; 1984 Apr; 86(4):780-2. PubMed ID: 6230281
    [No Abstract]   [Full Text] [Related]  

  • 2. Dysregulation of blood lymphocyte subsets and natural killer cells in schistosomal liver cirrhosis and hepatocellular carcinoma.
    Attallah AM; Tabll AA; El-Sadany M; Ibrahim TA; El-Dosoky I
    Clin Exp Med; 2003 Nov; 3(3):181-5. PubMed ID: 14648234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of subsets of lymphocytes infiltrating head and neck tumor tissue: a preliminary report.
    Rabin BS; Johnson J; Claassen D
    Laryngoscope; 1984 May; 94(5 Pt 1):688-90. PubMed ID: 6232437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of the cytotoxic/suppressor T-cell subset in liver tissue injury of patients with acute and chronic liver diseases.
    Pape GR; Rieber EP; Eisenburg J; Hoffmann R; Balch CM; Paumgartner G; Riethmüller G
    Gastroenterology; 1983 Sep; 85(3):657-62. PubMed ID: 6307807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner.
    Ghiringhelli F; Ménard C; Terme M; Flament C; Taieb J; Chaput N; Puig PE; Novault S; Escudier B; Vivier E; Lecesne A; Robert C; Blay JY; Bernard J; Caillat-Zucman S; Freitas A; Tursz T; Wagner-Ballon O; Capron C; Vainchencker W; Martin F; Zitvogel L
    J Exp Med; 2005 Oct; 202(8):1075-85. PubMed ID: 16230475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Stem cell inactivation by allogenic lymphocytes: characteristics of suppressor cells blocking the killer action of syngeneic lymphocytes].
    Ignat'eva GA; Man'ko VM; Dishkant IP
    Tsitologiia; 1981 Dec; 23(12):1386-94. PubMed ID: 6460363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proliferation of T gamma cells with killer-cell activity in patients with neutropenia.
    Ceuppens J
    N Engl J Med; 1980 Oct; 303(15):882. PubMed ID: 6447834
    [No Abstract]   [Full Text] [Related]  

  • 8. [Subpopulations of human T-lymphocytes and their suppressor functions].
    Brondz BD
    Ter Arkh; 1980; 52(9):120-32. PubMed ID: 6449090
    [No Abstract]   [Full Text] [Related]  

  • 9. [Prospect of liver immunology: a report from the 59th Annual Meeting of the American Association for the study of liver diseases].
    Yan WM; Ning Q
    Zhonghua Gan Zang Bing Za Zhi; 2009 Mar; 17(3):235-7. PubMed ID: 19335995
    [No Abstract]   [Full Text] [Related]  

  • 10. Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes.
    Brillard E; Pallandre JR; Chalmers D; Ryffel B; Radlovic A; Seilles E; Rohrlich PS; Pivot X; Tiberghien P; Saas P; Borg C
    Exp Hematol; 2007 Mar; 35(3):416-25. PubMed ID: 17309822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional ontogeny of human lymphoid cells as a factor in maternal-fetal tolerance.
    Siegal FP
    Prog Clin Biol Res; 1981; 70():41-6. PubMed ID: 6458825
    [No Abstract]   [Full Text] [Related]  

  • 12. [Current concepts of the growth mechanisms of the immune response].
    Voĭtenok NN
    Ter Arkh; 1980; 52(9):132-40. PubMed ID: 6449091
    [No Abstract]   [Full Text] [Related]  

  • 13. T gamma and T mu lymphocytes. Clinical and experimental studies of human T gamma and T mu lymphocytes participating in the immune response.
    Jensen JR
    Dan Med Bull; 1984 Apr; 31(2):73-89. PubMed ID: 6233103
    [No Abstract]   [Full Text] [Related]  

  • 14. The "End of the beginning" of the immunobiology of iNKT cells in health and disease.
    Delovitch TL
    Int Rev Immunol; 2007; 26(1-2):1-3. PubMed ID: 17454261
    [No Abstract]   [Full Text] [Related]  

  • 15. To be or not to be NKT: natural killer T cells in the liver.
    Exley MA; Koziel MJ
    Hepatology; 2004 Nov; 40(5):1033-40. PubMed ID: 15486982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The current immune function of hepatic dendritic cells.
    Hsu W; Shu SA; Gershwin E; Lian ZX
    Cell Mol Immunol; 2007 Oct; 4(5):321-8. PubMed ID: 17976311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of immune functions in the fetus and newborn.
    Murgita RA; Wigzell H
    Prog Allergy; 1981; 29():54-133. PubMed ID: 6460251
    [No Abstract]   [Full Text] [Related]  

  • 18. Characterization of rat spleen cell populations. II. Activation by antigens and allogeneic cells.
    Rocha B; Freitas AA; Parrott D
    Immunology; 1980 Dec; 41(4):825-32. PubMed ID: 6450728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human T-cell growth factor (TCGF).
    Sarin PS; Gallo RC
    Crit Rev Immunol; 1984; 4(4):279-305. PubMed ID: 6232114
    [No Abstract]   [Full Text] [Related]  

  • 20. Adoptive transfer of spleen cells from mice treated with radioactive strontium: suppressor cells, natural killer cells, and "hybrid resistance" in recipient mice.
    Levy EM; Bennett M; Kumar V; Fitzgerald P; Cooperband SR
    J Immunol; 1980 Feb; 124(2):611-8. PubMed ID: 6444313
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.